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ABSTRACT
DmTTF is a Drosophila mitochondrial DNA-binding
protein, which recognizes two sequences placed at
the boundary of clusters of genes transcribed in
opposite directions. To obtain in vivo evidences on
the role of DmTTF, we characterized a DmTTF knock-
down phenotype obtained by means of RNA interfer-
ence in D.Mel-2 cells. By a combination of RNase pro-
tection and real-time RT–PCR experiments we found
that knock-down determines remarkable changes in
mitochondrial transcription. In particular, protein
depletion increases not only the level of (1) and
( )strand RNAs mapping immediately after of the
two protein-binding site, but also that of transcripts
locatedfurtherdownstream.Unexpectedly,depletion
of the proteinalso causes the decrease in the content
of those transcripts mapping upstream of the protein
target sites, including the two rRNAs. The changes in
transcript level do not depend on a variation in
mitochondrial DNA (mtDNA) content, since mtDNA
copy number is unaffected by DmTTF depletion.
This work shows conclusively that DmTTF arrests
in vivo the progression of the mitochondrial RNA
polymerase; this is the first ever-obtained evidence
for an in vivo role of an animal mitochondrial tran-
scription termination factor. In addition, the reported
dataprovideinterestinginsightsintotheinvolvement
of DmTTF in transcription initiation in Drosophila
mitochondria.
INTRODUCTION
Mitochondrial DNA (mtDNA) transcription in animals [for
review see (1,2)] requires the catalytic activity of an
organelle-speciﬁc RNA polymerase (mtRNApol), a mono-
meric protein showing signiﬁcant similarity to bacteriophage
RNA polymerases (3), and some accessory factors. They
include TFAM and TFB1/2M, involved in transcription initi-
ation, and a protein responsible for transcription termination.
TFAM acts as a DNA-binding protein that recognizes pro-
moters in a sequence-speciﬁc manner and stimulates transcrip-
tion (4,5); moreover it possesses the property of non-speciﬁc
DNA binding (6) and exerts an architectural role in the main-
tenance of mtDNA (7,8). TFB1/2M are two related factors that
are required for basal transcription, with TFB2M being about
two orders of magnitude more active in promoting speciﬁc
transcription than TFB1M (5). The proposed model for tran-
scription initiation requires TFBM proteins to bridge an inter-
action between mtRNApol and promoter-bound TFAM (9).
So far, in vivo studies for TFB1/2M have been performed only
in Drosophila that allowed ascribing a different role to each
of them. In particular, TFB2M regulates mtDNA transcription
and copy number (10), whereas TFB1M modulates mitochon-
drial translation but not transcription or mtDNA copy number
in Schneider cells (11). The role of TFB1M in mitochondrial
translation is probably related to the RNA methyltransferases
activity described for this protein (12).
Transcription terminationfactorshave beencharacterizedin
human (13,14), sea urchin (15,16) and Drosophila (17,18);
they belong to a wide family of proteins identiﬁed in several
animal phyla (19). Termination factors display sequence-
speciﬁc DNA-binding activity and the capacity to arrest
in vitro the progression of the mtRNApol in a bidirectional
way. In spite of these common features, the location of target
sites on mtDNA and the speciﬁc role accomplished by the
termination factors seem to vary in the different species
according to the peculiar mtDNA gene organization and the
transcription mechanism. The human factor mTERF binds
mtDNA immediately downstream of the 30 end of the ribo-
somal gene unit and is thought to be responsible for an
attenuation/termination event that causes the steady-state
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doi:10.1093/nar/gkl181level of rRNAs to be higher than that of the downstream
mRNAs (20). Most recently, a second DNA-binding site
has been detected for mTERF in the D-loop region of
mtDNA (21). The sea urchin factor mtDBP recognizes two
homologous sequences located in the main non-coding region
and at the ND5/ND6 gene boundary, respectively. Also the
Drosophila factor DmTTF recognizes two homologous
sequences on mtDNA that lie at the boundary of clusters of
genes transcribed in opposite direction, namely the boundary
ND3/ND5 and cyt b/ND1. The position and the number of the
binding sites point to the involvement of these factors in con-
trolling the multiple transcription units existing in these organ-
isms. Contrary to human mTERF, the sea urchin and
Drosophila proteins do not bind at the 30 end of the ribosomal
genes and do not seem to be directly involved in the regulation
of rRNA level. An additional role in mtDNA replication has
been proposed for sea urchin mtDBP, that has been demon-
strated in vitro to posses also a contrahelicase activity (22).
Despite the multiplicity of data produced by in vitro studies,
no evidence has been reported so far demonstrating in vivo the
capacity of a mitochondrial transcription termination factor to
arrest mtRNApol, and, more in general, to affect transcription.
With the aim to study in vivo the role of DmTTF, we used
Drosophila melanogaster cultured cells as a model system to
obtain a knock-down phenotype. Our results indicate that
DmTTF depletion causes a general increase in the level of
sense and antisense transcripts mapping downstream of
DmTTF binding sites on either strands. This allows to con-
clude that removal of the protein facilitates the progression of
mtRNApol in both directions. Moreover, we found that knock-
down of DmTTF affects the level of transcripts mapping
upstream of the protein-binding site.
MATERIALS AND METHODS
Drosophila cell culture and conditions for RNAi
Drosophila embryonic cell line D.Mel-2 (GIBCO-Invitrogen)
was maintained in Drosophila SFM (GIBCO-Invitrogen)
supplemented with 16 mM L-glutamine, 50 U/ml penicillin
and 50 mg/ml streptomycin, at 28 Ci n7 5c m
2 ﬂasks. For
double-stranded RNA (dsRNA) treatment, the cells were
diluted to a ﬁnal concentration of 1.0 · 10
6 cells/ml in
10 ml of complete Drosophila SFM in 75 cm
2 ﬂasks.
dsRNA (15 mg per 10
6 cells) was added directly to the medium
to a ﬁnal concentration of 30 nM. Flasks were swirled by hand
and the cells were incubated at 28 C for 1 h. Then, 10 ml of
medium were addedto obtain a cell density of 0.5 · 10
6cells/ml,
an additional incubation at 28 C for 72 h followed.
dsRNA production
The templates for the production of dsRNA were PCR-derived
fragments carrying at both ends the T7 promoter sequence.
Each primer used in the PCR contained a 50 end sequence
corresponding to the T7 polymerase promoter (TAATACGA-
CTCACTATAGGGA), followed by a gene-speciﬁc sequence
as indicated: DmTTF (accession no. AY196479) forward-
primer 506–521, reverse-primer 1223–1207; odds-paired
(accession no. NM_079504) forward-primer 270–285,
reverse-primer 987–972. The PCR products were puriﬁed
by the Wizard SV PCR Clean-Up System (Promega) and
used as templates for the MEGAscript T7 transcription kit
(Ambion) to produce dsRNA according to the manufacturer’s
instructions.
Protein extract preparation and western blotting
analysis
dsRNA treated and untreated D.Mel-2 cells were harvested,
centrifugedat1000ginthe Eppendorf A-4-62rotor for 4 minat
4 C and washed twice in D-PBS (Euroclone). To prepare total
protein extract, pellets were resuspended in NP-40 lysis buffer
[25 mM Tris–HCl (pH 8.0), 5mM MgCl2, 0.5 mM EDTA, 400
mM KCl, 20% glycerol, 1% Nonidet P-40, 1 mM DTT and
protease inhibitors (Sigma)], homogenized and centrifuged at
130 000 g in the Beckman 70.1 Ti rotor for 30 min at 4 C. To
obtainmitochondrialproteinextract,cellswereresuspendedin
10 mM Tris–HCl (pH 6.7), 10 mM KCl, 0.1 mM EDTA.
Mitochondria were prepared as described by Ausenda and
Chomyn (23) and lysed in NP-40 lysis buffer in the same
conditions used for total cell lysate. Total and mitochondrial
lysates, containing 250 mg of proteins, were fractionated on
12% SDS–polyacrylamide gel and electroblotted for 1 h to
PVDF membrane (Hybond-P, Amersham Pharmacia). Mem-
branes were pre-incubated for 1 h with 1· Blotto [20 mM Tris
(pH 7.5), 150 mM NaCl, 1% Triton X-100] containing 5%
non-fat dry milk, followed by incubation for 1 h, in the same
solution, with polyclonal antibodies raised in guinea pig
against recombinant DmTTF (Eurogentec) and in rabbit
against recombinant D-TFAM and h-NDUFS4 (kindly pro-
vided by Y. Kitagawa, Nagoya University, Japan, and
S. Scacco, University of Bari, Italy, respectively). Filters were
washed four times for 15 min with 1· Blotto / 5% non-fat dry
milk, incubated for 1 h with horseradish peroxidase (HRP)-
coniugated anti-guinea pig IgG or anti-rabbit IgG (Santa Cruz
Biotechnology) and washed with 1· Blotto. Protein bands
were visualized using the ECL western blotting reagents
(Amersham Pharmacia).
RNase protection assay
Total cellular RNA was extracted from treated and untreated
D.Mel-2cells bytheRNeasyMidiKit(Qiagen).Thetemplates
for the production of riboprobes Ribo-1 and Ribo-2 were PCR-
derived fragments carrying at one end the T7 promoter poly-
merase sequence. The reverse primers used in the PCR
contained a 50 end sequence corresponding to the T7 pro-
moter (TAATACGACTCACTATAGG), followed by a
D.melanogaster mtDNA-speciﬁc sequence (accession no.
NC_001709). Primer sequences were: forward-primer
11637–11661 and reverse-primer 11931–11908 for Ribo-1;
forward-primer 11637–11661 and reverse-primer 11855–
11834 for Ribo-2. The PCR products were puriﬁed by the
Wizard SV PCR Clean-Up System (Promega) and used as tem-
plates to produce
32P-labeled riboprobes with the MAXIscript
T7 kit (Ambion), according to the manufacturer’s instructions.
RNase protection assay was performed by using the RPA III
kit (Ambion) with some modiﬁcations. For each sample,
about 1.5 · 10
5 c.p.m. of gel-puriﬁed riboprobes were
co-precipitated with 50 mgo fDrosophila total RNA in the
presence of 0.5 M ammonium acetate and 2.5 vol of absolute
ethanol. RNA pellets were dissolved in 10 ml of hybridization
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50% ultrapure formamide], denaturated for 4 min at 95 C and
incubated for 16 h at 37 C. Hybrids were digested in 150 mlo f
RNase Digestion III buffer (Ambion) in the presence of 2.5 U/
ml of RNase A and 100 U/ml of RNase T1 for 30 min at 37 C.
Digestion products were ethanol precipitated and pellets were
resuspended in gel loading buffer II (Ambion), denatured and
run on 10% polyacrylamide/7 M urea gels in TBE. Bands were
visualized by Typhoon 8600 Phosphor Imaging System
(Molecular Dynamics) and the quantitative analysis was per-
formed with ImageQuant 5.2 software (Molecular Dynamics).
RT–PCR and real-time RT–PCR assays
Semiquantitative RT–PCR assay was performed using the
Enhanced Avian HS RT–PCR Kit (Sigma) according to the
manufacturer’s instruction. Reactions contained 600 ng of
Drosophila total RNA as template, and 100 pmol primers
speciﬁc for Drosophila mtDNA or 28S RNA (endogenous
control) in a ﬁnal volume of 100 ml.
For real-time RT–PCR assay, RNA was reverse-transcribed
using the Enhanced AMV Reverse Transcriptase (Sigma),
according to the manufacturer’s instruction. Each reaction
was carried out in a ﬁnal volume of 25 ml using 250 ng of
total RNA and 25 pmol of mtDNA gene-speciﬁc primer.
Forward or reverse primer was added to select the sense or
antisense mitochondrial transcripts. Real-time PCR was
performed using the SYBR  Green PCR MasterMix (Applied
Biosystems) and the ABI PRISM 7000 Sequence Detection
System (Applied Biosystems). Primers were designed using
the Primer Express 2.0 software (Applied Biosystem) and
sequence positions on D.melanogaster mtDNA were as fol-
lows: ND2-for 558–573 nt, ND2-rev 651–632 nt; tRNA
Cys-for
1322–1346 nt, tRNA
Cys-rev 1383–1357 nt; COI-for
1838–1862nt,COI-rev1932–1904nt;COII-for3569–3593nt,
COII-rev 3652–3631 nt; ATPase6-for 4409–4433 nt,
ATPase6-rev 4481–4459 nt; COIII-for 5304–5328 nt,
COIII-rev 5379–5355 nt; ND5-for 7040–7061 nt, ND5-rev
7114–7095 nt; cyt b-for 10 697–10 719 nt, cyt b-rev
10766–10 748 nt; ND1-for 11 984–12 002 nt, ND1-rev
12056–12 034 nt; lrRNA-for 12 827–12 845 nt, lrRNA-rev
12906–12 887 nt; srRNA-for 14 407–14 434 nt, srRNA-rev
14484–14 462 nt. Cytoplasmic 28S rRNA (accession no.
M21017) was used as endogenous control; primer sequence
positions were: 28S-for 1407–1429 nt, 28S-rev 1480–1462 nt.
Each reaction was run in triplicate and contained 1 mlo f
reverse transcription reaction (1 ml of a 1:300 dilution was
used for 28S rRNA) along with 200 nM primers in a ﬁnal
reaction volume of 30 ml. Ampliﬁcation conditions were: 95 C
for 10 min, then 40 cycles of 95 C for 15 s and 60 C for 1 min.
To ensure that only a single product was ampliﬁed, the melting
curve analysis was performed; it took an additional step of
20 min after the real-time PCR, and was carried out using the
Dissociation Curves software (Applied Biosystem). All PCR
products were run on a 2.5% agarose gel to conﬁrm speciﬁcity.
The ampliﬁcation plots produced during real-time PCR were
used to determine the ampliﬁcation efﬁciency for each amp-
licon with the formula E ¼ 10
 1/slope. The relative quantiﬁca-
tion of target transcripts in RNAi cells compared to untreated
cells, allnormalizedto28SrRNA,wasperformed accordingto
the Pfafﬂ mathematical model (24). For each amplicon, the
mean ratio value was obtained from at least four real-time
RT–PCR assays, using RNA obtained from independent
RNAi experiments. Statistical analysis was performed using
paired two-tailed Student’s t-test.
Southern blotting analysis
Total cellular DNA was extracted from treated and untreated
D.Mel-2 cells by the Wizard Genomic DNA Puriﬁcation kit
(Promega). DNA was digested with XhoI, fractionated on a
0.7% agarose/TAE gel (5 mg/lane) and electrotransferred to
nylon ﬁlters (Hybond-N
+,Amersham Biosciences).Blots were
hybridized to
32P-labeled probes for the ND3 gene
(5720–5930 nt) and for the nuclear histone gene H2B (acces-
sionno.X14215,416–787nt).Hybridizationwasperformedin
6· SSC [900 mM NaCl, 90 mM sodium citrate (pH 7.0)], 5·
Denhardt’s reagent, 0.5% SDS, 100 mg/ml of salmon sperm
DNA at 68 C for 16 h. The membrane was washed twice at
room temperature for 10 min in 2· SSC, 0.1% SDS, at 65 C
for 30 min in 0.1· SSC, 0.1% SDS and ﬁnally at room
temperature for 5 min in 0.1· SSC. Filters were analyzed
as reported for RNase protection assay.
RESULTS
RNAi-mediated knock-down of DmTTF
To in vivo analyze the role of the Drosophila transcription
termination factor DmTTF, we produced a knock-down
phenotype in D.Mel-2 cultured cells by using the RNAi
technique. DmTTF level was monitored by means of western
blotting using speciﬁc polyclonal antibodies raised against the
bacterial recombinant protein (17). The antiserum was tested
with total cellular proteins and with mitochondrial protein
extract (Figure 1A); in both cases, the antibodies detected a
polypeptide showing an approximate molecular mass of
43 kDa. This result represents the ﬁrst detection of the natural
form of DmTTF and conﬁrms the calculated mass of the
mature protein. Mitochondrial lysate appears highly enriched
in DmTTF as expected for a mitochondria-localized protein.
DmTTF-targeted RNAi was accomplished by treating
D.Mel-2 cells with dsRNA for DmTTF. After 72 h of
incubation cells were harvested and mitochondrial proteins
were extracted and tested by western blotting. As shown
in Figure 1B, DmTTF was not detectable in mitochondrial
lysates from DmTTF-dsRNA treated cells. The interference
was speciﬁc since no effect was obtained in cells treated with
dsRNA containing the sequence of Opa1 gene (mock control).
Moreover, the intensity of the band corresponding to
D-NDUFS4, a nuclear-encoded subunit of NADH dehydro-
genase used as loading control, remained almost unchanged in
all cases. A longer exposure of the membrane (data not shown)
indicated that >90% depletion of DmTTF was obtained. In
addition, we tested whether the knocking down of DmTTF
might have affected the level of another mitochondrial tran-
scription factor, namely D-TFAM. Figure 1B shows that
D-TFAM content remained unchanged in treated and
untreated cells, thus indicating that DmTTF knock-down
did not affect D-TFAM expression. No changes in cell
viability and morphology were observed following the treat-
ment with dsRNA for DmTTF.
Nucleic Acids Research, 2006, Vol. 34, No. 7 2111DmTTF depletion affects transcription in
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The molecular effect of DmTTF knock-down on mitochon-
drial transcription was investigated by means of different strat-
egies. Firstly, we focused our attention on transcripts mapping
in proximity of the cyt b/ND1-binding site. In particular, we
performed an RNase protection assay using two overlapping
riboprobes of 295 nt (Ribo-1) and 218 nt (Ribo-2), that are
complementary to ( )strand transcripts and share the same
30 end (Figure 2A). After RNase treatment, hybrids were sized
by denaturing polyacrylamide gel electrophoresis. Figure 2B
shows that, in control cells, Ribo-1 produced a prominent band
of 67 nt corresponding to the tRNA
Ser(UCN) that is entirely
contained in the probe, and few additional faint bands having
a higher molecular weight. In DmTTF knock-down cells, in
addition to the 67 nt band, which is 30% more intense than in
the control, many other higher molecular weight hybrids, that
were about 5-fold more abundant than in the control, were
detected. The size of the slowest migrating band, about 230 nt,
was consistent with that of the portion of ND1-antisense tran-
script extending from DmTTF-binding site to the 50 end of the
probe. These results were conﬁrmed by a similar experiment
using the shorter probe Ribo-2. In control cells we observed
again a prominent band of 67 nt along with minor higher
molecular weight products. However in knock-down cells,
the 67 nt band, which was again 30% more abundant than
in the control, was accompanied by additional slow migrating
products that were about 5-fold more abundant and reached a
maximum size of about 150 nt. Also in this case the dimension
A
B
Figure 1. Effect of DmTTF-targeted RNAi in D.Mel-2 cells. (A) Western
blotting analysis of D.Mel-2 total cell and mitochondrial lysate. A total of
250 mg of proteins were fractionated on a 12% SDS–polyacrylamide gel,
electroblottedtoPVDFfiltersandincubatedwithpolyclonalantibodiesagainst
recombinant DmTTF. (B) D.Mel-2 cells were either untreated (control) or
treated with odds-paired (Opa1) or DmTTF dsRNA. Mitochondrial lysate
(250 mg of proteins) was probed with polyclonal antibodies against DmTTF,
h-NDUFS4 or D-TFAM.
A
B
Figure 2. RNase protection assay on mitochondrial ( )strand transcripts map-
ping around the cyt b/ND1-binding site in DmTTF-depleted cells. (A) Sche-
matic representation of digestion products using probes Ribo-1 (295 nt) and
Ribo-2(218nt).Riboprobes(greyboldarrows),maturetranscripts(continuous
arrows)andread-throughtranscripts(dottedarrows)areindicatedabovethecyt
b/ND1 region map. Dashed regions indicate non-coding sequences. (B) Total
cellular RNA (50 mg), extracted from untreated (control) and DmTTF-dsRNA
treated (RNAi) D.Mel-2 cells, was hybridized with about 1.5 · 10
5 c.p.m. of
Ribo-1 and Ribo-2 probes and digested with RNase A and T1. Digestion
products were denatured and run on a 10% polyacrylamide/7 M urea gel.
Y, sample containing 50 mg of yeast total RNA. M, Decade RNA marker
(Ambion).
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protected by Ribo-2. The low intensity of the highest molecu-
lar weight bands (230 and 150 nt) obtained with both
riboprobes is very likely due to the high A:T content of
Drosophila mtDNA sequence that could make hybrid ends
unstable and therefore highly susceptible to RNase digestion.
No precursor transcripts, including both tRNA
Ser(UCN) and the
portion of ND1-antisense contained in the probe, were detect-
able probably due to the very low abundance of unprocessed
precursor molecules.
We used the more sensitive RT–PCR to detect RNA
molecules spanning the cyt b/ND1-binding site in knock-down
and control cells. By using two primers located respectively
upstream and downstream of the termination site, we carried
out a semi-quantitative analysis by taking samples at different
time points (Figure 3). The ampliﬁcation product of 360 bp,
deriving from precursor transcripts encompassing the 30 ends
of cyt b and ND1 genes, appears almost ﬁve cycles earlier in
treated cells than in the control. Although this analysis does
not allow to distinguish between (+) and ( )strand transcripts,
the obtained results indicate that mitochondria from both
control and depleted cells contain unprocessed precursor tran-
scripts spanning DmTTF-binding sites and that those
molecules are more abundant in DmTTF-depleted cells.
DmTTF depletion causes a general alteration of
mitochondrial transcription
The above reported data show that DmTTF knock-down
causes the increase in the level of transcripts mapping beyond
thecytb/ND1-bindingsite.Toexaminewhetherproteindeple-
tion may have a wider impact on mitochondrial transcription,
we performed a systematic analysis based on the measurement
of the steady-state level of several mitochondrial RNA species
by means of real-time RT–PCR. In particular, we determined
the relative concentration of 11 sense and 9 antisense tran-
scripts located upstream and downstream of the two
DmTTF-binding sites, and we calculated for each transcript
the ratio between knock-down and control cells.
The results are shown in Figure 4A. Starting from the
tRNA
Ile gene and proceeding in the direction of ( )strand
transcription, we found that the level of several transcripts
mapping upstream of the ND3/ND5-binding site, namely
ND2, tRNA
Cys-antisense, COI, COII, COIII, was 1.5- to
2-fold reduced in knock-down cells. The only exception
was ATPase6/8 transcript that remained substantially
unchanged. On the contrary, the content of transcripts
mapping downstream of the ND3/ND5-binding site, namely
ND5-antisense and cyt b, almost doubled in knock-down cells
with respect to the control. A higher increase (about 3-fold) of
the levelofND1-antisense transcript, which maps downstream
of the cyt b/ND1-binding site, occurred in knock-down cells.
The relative increase in the level of ND1-antisense transcript
measured by real-time RT–PCR is in agreement with that
deduced by RNase protection assay.
Thelevel of(+)strandtranscriptsdisplayedatrendsimilarto
that of the ( )strand RNA molecules. Starting from the srRNA
and moving in the (+)strand transcription direction, we
observed that in knock-down cells the level of srRNA,
lrRNA and ND1 transcripts, all mapping upstream of the
cyt b/ND1-binding site, declined by a factor of 2. On the
contrary the content of cyt b-antisense and ND5 transcripts,
which are placed downstream of the protein-binding site, is
markedly increased as it doubles with respect to the control.
Finally, we measured the abundance of transcripts mapping
downstream of the ND3/ND5-binding site. We found that,
with the only exception of COIII-antisense that remained
unchanged, the level of ATPase6/8-antisense, COII-antisense,
COI-antisense, tRNA
Cys and ND2-antisense transcripts was
markedlyincreasedindepleted cells, withND2-antisensetran-
script level reaching a value that was about 10-fold than in the
control. We conclude that DmTTF depletion has a wide effect
on mitochondrial transcription, causing the increase in the
level of transcripts mapping downstream of one or both target
sites, and the decrease in the level of transcripts mapping
upstream of both target sites.
To evaluate the possibility that DmTTF depletion could
affect mtDNA copy number, we determined the ratio between
mtDNA and nuclear DNA, in both control and DmTTF
depleted cells. For this purpose, total cellular DNA was
cleaved with XhoI and analyzed by Southern blotting using
a probe for the mitochondrial ND3 gene and a probe for the
nuclear H2B histone gene. The results of a representative
experiment are shown in Figure 4B. It appears that there is
no signiﬁcant change in mtDNA level in knock-down cells;
this was conﬁrmed by measuring the relative mtDNA content
by real-time PCR (data not shown). This result indicates that
changesintheconcentration ofmitochondrialRNAsaredueto
a direct effect of DmTTF depletion on mitochondrial tran-
scription rather than to changes in mtDNA content.
DISCUSSION
Mitochondrial transcription termination factors are sequence-
speciﬁc DNA-binding proteins characterized in mammals
(13), echinoderms (15) and Drosophila (17). Their function
has been inferred from the capacity of arresting in vitro
A
B
Figure 3. RT–PCR analysis on mitochondrial transcripts spanning the
cyt b/ND1-binding site in DmTTF-depleted cells. (A) Schematic illustration
of the cyt b/ND1-binding site. Black arrows represent the forward
(11494–11520 nt) and reverse (11 855–11 834 nt) primers used for RT–PCR.
Dashed regions indicate non-coding nucleotides. (B) Total RNA (600 ng)
extracted from untreated (control) and treated (RNAi) D.Mel-2 cells was used
as template in RT–PCR; 10 ml-samples were collected at the indicated cycles,
runona1.5%agarosegelandstainedwithethidiumbromide.Nuclearencoded
28S rRNA was used as endogenous control.
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role has never been demonstrated in vivo. We have previously
reported that DmTTF, the transcription termination factor of
Drosophila mitochondria, recognizes two sequences placed at
the boundary of clusters of genes transcribed in opposite direc-
tions and stops the progression of human mtRNApol in a
bidirectional way. In the present work, we provide in vivo
evidences on the role of DmTTF in transcription by charac-
terizing a DmTTF knock-down phenotype obtained by means
of RNAi in Drosophila cultured cells.
By a combination of RNase protection and RT–PCR experi-
ments, we found that DmTTF depletion greatly affects the
level of mitochondrial transcripts mapping around the
cyt b/ND1-binding site. We showed that ( )strand processed
transcripts extending beyond the putative termination site and
precursor RNA molecules spanning DmTTF-binding site are
both remarkably more abundant in knock-down cells. These
ﬁndings constitute the ﬁrst in vivo indication that DmTTF
represents a hindrance to the progression of mtRNApol. A
further support to this view was provided by the results of
the extensive analysis performed on sense and antisense tran-
scripts by real-time RT–PCR. With a few exceptions, we
found in depleted cells an increase of about 2-fold in the
level of those transcripts that map on either strand downstream
of one or both DmTTF-binding sites. This increase is even
more signiﬁcant if compared to the 50% reduction of the level
of the transcripts mapping upstream of both DmTTF target
sites on either strand. Therefore, our results show a clear cor-
relation between the removal of the protein and an enhanced
read-through transcription downstream of the protein-binding
sites, thus providing conclusive evidence of the in vivo role of
DmTTF as transcription termination factor. RNase protection
experiments also indicated that DmTTF-mediated transcrip-
tion termination is not responsible for the production of the
30 terminus of those RNA molecules mapping just upstream of
the protein-binding site, since depletion of the protein did not
affect the size of tRNA
Ser(UCN). On this basis, contrary to what
suggested earlier (25), it is conceivable that mitochondrial
termination factors are not involved in the generation of the
30 end of RNA molecules. Recently in Drosophila it has been
characterized RNase Z, an endonucleolytic activity that is
responsible for the speciﬁc cleavage at the 30 end of mitochon-
drial tRNAs (26). A further interesting result derives from
real-time RT–PCR experiments. As mentioned above, in
A B
Figure 4. Effect of DmTTF depletion on the level of mitochondrial sense and antisense transcripts, and on mtDNA copy number. (A) Relative quantification of
mitochondrial RNAs by real-time RT–PCR. MtDNA molecule is represented as a linear map. Transcription direction of ( ) and (+)strand is indicated by black
arrows; the two DmTTF-binding sites are marked by vertical dotted lines. Black bars reported above ( )strand and below (+)strand, in correspondence of the
analyzedgenes,indicatetherelativecontent(R)ofsenseandantisensetranscripts,normalizedto28SrRNA(endogenouscontrol),inDmTTFdepleted(RNAi)with
respect to control cells, fixed as value 1. The relative quantification was performed according to the Pfaffl equation R ¼ (ET)
DCt,T/(EC)
DCt,C (24), where ET is the
amplification efficiency of target gene transcripts; EC is the amplification efficiency of endogenous control; DCt,T and DCt,C are the differences between Ct of the
controlandCtoftheRNAisamplefortargetgenetranscriptsandforendogenouscontrol,respectively.Foreachamplicon,themeanratiovaluewasobtainedfromat
least four real-time RT–PCR assays, using RNA obtained from independent RNAi experiments; standard deviations are indicated on the top of the bars. Statistical
analysis showed that the differences between RNAi and control are all significant (P < 0.05) except for ATPase6/8 and COIII-antisense transcript. (B) Southern
blottinganalysisofmtDNA.TotalDNA(5mg)fromuntreated(control)andtreated(RNAi)D.Mel-2cellswasdigestedwithXhoI,fractionatedona0.7%agarosegel
and electroblotted to nylon membrane. The filter was hybridized with radiolabeled probes for both mitochondrial ND3 gene and nuclear H2B histone gene
(endogenous control). The amount of c.p.m. used for each probe was such to obtain a comparable signal for mitochondrial and nuclear DNA.
2114 Nucleic Acids Research, 2006, Vol. 34, No. 7knock-down cells the amount of (+) and ( )strand transcripts
mapping upstream of both DmTTF-binding sites was, in most
of the cases, reduced of about 50%. A possible explanation for
this decrease could be a direct involvement of DmTTF in
transcription initiation since the affected transcripts map
downstream of the A+T region (27), which should contain
at least one initiation site for each strand. Very recently it
has been demonstrated the capacity of the human mitochon-
drial transcription termination factor mTERF to bind mtDNA
in the D-loop region, in proximity of the H-strand promoter,
and to stimulate rRNAs synthesis via a mtRNApol recycling
process (21). A similar mechanism could take place for
DmTTF, considering that several sequences highly homolog-
ous to DmTTF-binding site are present in the A+T region.
Alternatively, the decreased transcription could be due to
the reduced availability of mtRNApol molecules for initiation
eventssinceinknock-downcellstheenzyme couldbeengaged
in aberrant transcription extending beyond the termination
sites, or forced to pause by the collision of the oppositely
moving transcription apparatus. Finally, we cannot rule out
that secondary, indirect effects acting at posttranscriptional
level also play a role in determining mitochondrial RNA levels
in DmTTF knock-down cells. They may result in an altered
stability of RNA molecules, possibly as a consequence of
compensative response mechanisms (28). These effects
could explain the observed exceptions and ﬂuctuations in
the variations of RNA levels.
It has been recently reported that mtDBP, the sea urchin
homologue of DmTTF, besides to function as transcription
termination factor, can regulate mtDNA replication since it
also possesses a contrahelicase activity (22). We found that in
Drosophila mitochondria the knock-down of DmTTF did not
change mtDNA copy number. On this basis we conclude that
the observed variations in the mitochondrial transcript level do
not depend on changes of mtDNA content. On the other hand a
direct involvement of DmTTF in mtDNA replication cannot
be completely ruled out since in our experimental system
duration and penetrance of RNAi could be not sufﬁcient to
reveal differences in mtDNA level given the lower turnover
rate of mtDNA as compared to mitochondrial RNAs.
With a few exceptions, Drosophila mitochondrial genes are
arranged to form four clusters alternatively distributed on the
two strands. Despite the extensive knowledge about transcrip-
tion factors, information on transcription mechanism of
Drosophila mtDNA is very limited. The data here reported
show that both strands are entirely transcribed, since in control
cells we detected allthe antisenseRNAswe investigated.They
also allow proposing two possible models of transcription.
According to the ﬁrst (see model I in Figure 5), transcription
of each strand should depend on only one promoter located in
the A+T region. This model is in agreement with the complete
transcription of mtDNA and requires the two DmTTF–DNA
complexes to function mostly as attenuators rather than ter-
minators. As shown in Figure 5, DmTTF bound to ND3/ND5
site would act as attenuator in both directions. At cyt b/ND1
site DmTTF would act as attenuator only in the direction of the
(+)strand transcription, whereas in the opposite direction, the
protein could serve as true terminator since no coding
sequences are present downstream of the protein-binding
site. The attenuation function of the human termination factor
mTERF has been shown to be responsible for the difference of
the levels of mitochondria rRNAs relative to mRNAs (29).
According to the second model, transcription of each strand
should require at least two promoters, each located at the
50 end of a gene cluster (see model II in Figure 5). In this
case, DmTTF bound to cyt b/ND1 site would function as true
terminator in both directions, since (+)strand transcription
reinitiates downstream of that site; at ND3/ND5 site, the factor
should function as attenuator only in the direction of (+)strand
transcription to permit the synthesis of tRNA
Tyr, tRNA
Cys and
tRNA
Gln. This model is in agreement with the results of
mitochondrial RNA mapping experiments early reported by
Berthier et al. (30). In vitro transcription experiments showed
that DmTTF, as well as its sea urchin and human homologues,
terminates transcription with a biased efﬁciency depending on
the direction of elongating RNA polymerase (14,16,18). This
result, which could reﬂect a structural asymmetry of the
protein–DNA complex, is in agreement with the capacity of
the protein to function in vivo as both attenuator and termi-
nator. The different behaviours of DmTTF might also depend
on interactions with other factors. DmTTF belongs to a family
of proteins most of which have a still unknown function (19);
one or more of these proteins could selectively interact with
DmTTF and determine its role as attenuation or termination
factor.
Figure 5. ProposedmodelsofmtDNAtranscriptionmechanisminDrosophila.
Grey areas show the coding sequences on either strands; arrows indicate direc-
tionsof(+)and( )strandtranscriptioninitiatingfromtherespectivepromoters.
Dotted lines indicate attenuated transcription. T, termination; A, attenuation.
See text for explanation.
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